Ponatinib Manufacturer Suspends Distribution
Ponatinib Manufacturer Suspends Distribution
Filed under: drug treatment programs maryland
"We continue to work with the FDA to negotiate updates to the US prescribing information for Iclusig and implementation of a comprehensive risk mitigation strategy," Harvey J. Berger, MD, chairman and chief executive officer of Ariad, said in a webcast …
Read more on OncLive
Levin Brings Broad Experience to Post as APA's CEO and Medical Director
Filed under: drug treatment programs maryland
Saul Levin, M.D., has an extensive background in organized medicine, public health, and creating linkages between mental health treatment and primary care. … Levin was the founder and president of Access Consulting International, which provided …
Read more on Psychiatric News
FDA Makes Opioid Labeling Changes, Requires More Postmarketing Data …
Filed under: drug treatment programs maryland
According to Douglas Throckmorton, MD, deputy director for regulatory programs in the FDA's Center for Drug Evaluation and Research, the new labels “describe more clearly the risks and safety concerns associated with ER/LA opioids and will encourage …
Read more on Pain Medicine News